Reply to: "A New Approach to the Development of Disease-Modifying Therapies for PD"

Mov Disord. 2021 May;36(5):1281-1282. doi: 10.1002/mds.28588.

Authors

Karl Kieburtz^{1

2}, C Warren Olanow^{1

3}

Affiliations

¹ Clintrex Research Corporation, Sarasota, Florida, USA.
² Center for Health & Technology, University of Rochester, Rochester, New York, USA.
³ Department of Neurology and Department of Neuroscience, Mount Sinai School of Medicine, New York, New York, USA.

PMID: 33991446
DOI: 10.1002/mds.28588

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Pandemics*
Parkinson Disease* / epidemiology